-
11.
公开(公告)号:US11873305B2
公开(公告)日:2024-01-16
申请号:US17360593
申请日:2021-06-28
Applicant: Genentech, Inc. , Hoffmann-La Roche Inc.
Inventor: Haiming Zhang , Jie Xu , Georg Wuitschik , Remy Angelaud , Sebastian Herold , Alfred Stutz , Tobias Bruetsch , Johannes Burkhard
IPC: C07D209/10 , C07D487/04
CPC classification number: C07D487/04
Abstract: Provided herein are processes for the preparation of indolyl intermediates using Wenker Synthesis for the total synthesis of SERD compounds useful in the treatment of cancer.
-
公开(公告)号:US11066389B2
公开(公告)日:2021-07-20
申请号:US16718602
申请日:2019-12-18
Applicant: Genentech, Inc.
Inventor: Jinguang Lin , Alexandra Chestakova , Wei Gu , Hans Iding , Jing Li , Xin Linghu , Patrik Meier , Chunbo Sha , Jeffrey Stults , Youchu Wang , Haiming Zhang , Jianqian Zhang , Tao Zhang
IPC: C07D401/14 , C07D401/04 , A61P35/00 , A61P25/00 , A61P29/00 , C12P17/16
Abstract: The present invention provides a process for the manufacture of a compound of formula VIIIa and salts forms of VIIIa where Rc is an aryl sulfonic acid
-
公开(公告)号:US10385058B2
公开(公告)日:2019-08-20
申请号:US15841828
申请日:2017-12-14
Applicant: Genentech, Inc.
Inventor: Danial Beaudry , Theresa Cravillion , Francis Gosselin , Ngiap-Kie Lim , Sushant Malhotra , Qingping Tian , Haiming Zhang , Alexander Gmehling , Alec Fettes , Stephan Bachmann
IPC: C07D487/04 , B01J31/24
Abstract: Methods for preparing the Bruton's Tyrosine Kinase (“BTK”) inhibitor compound 2-{3′-hydroxymethyl-1-methyl-5-[5-((S)-2-methyl-4-oxetan-3-yl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-[3,4′]bipyridinyl-2′-yl}-7,7-dimethyl-3,4,7,8-tetrahydro-2H,6H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one are provided. Methods for preparing tricyclic lactam compounds are also provided.
-
公开(公告)号:US09975856B2
公开(公告)日:2018-05-22
申请号:US15287023
申请日:2016-10-06
Applicant: Genentech, Inc.
Inventor: Stephan Bachmann , Serena Maria Fantasia , Francis Gosselin , Chong Han , Stefan Hildbrand , Theresa Humphries , Christian Jenny , Ngiap-Kie Lim , Andrew McClory , Christian Moessner , Pankaj Rege , Scott Savage , Haiming Zhang
IPC: C07D231/56 , C07D405/04 , C07C309/73 , C07C69/73 , C07F5/04 , C07C69/612 , C07F5/02
CPC classification number: C07D231/56 , C07C69/612 , C07C69/73 , C07C69/738 , C07C309/73 , C07D405/04 , C07F5/025 , C07F5/04
Abstract: Processes are described for the preparation of estrogen receptor modulating compound, (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid I: and salts thereof, and intermediates useful for the preparation of I.
-
公开(公告)号:US09969735B2
公开(公告)日:2018-05-15
申请号:US15652776
申请日:2017-07-18
Applicant: Genentech, Inc.
Inventor: Ngiap-Kie Lim , Haiming Zhang , Chong Han
IPC: C07D471/14
CPC classification number: C07D471/14 , C07D471/04
Abstract: Processes are described for the preparation of tricyclic lactam compound of Formula (I), having the structure and intermediates useful for the preparation of (I).
-
公开(公告)号:US12071422B2
公开(公告)日:2024-08-27
申请号:US18164302
申请日:2023-02-03
Applicant: Genentech, Inc. , Hoffmann-La Roche Inc.
Inventor: Rene Lebl , Ngiap Kie Lim , Roland Christoph Meier , Ugo Jonathan Orcel , Joerg Sedelmeier , Jeff Shen , Lauren Elizabeth Sirois , Jacob C. Timmerman , Etienne Trachsel , Nicholas Andrew White , Jie Xu , Haiming Zhang , Stephan Bachmann , Thomas Michael Bass , Raphael Bigler , Johannes Adrian Burkhard , Kyle Bradley Pascual Clagg , Francis Gosselin , Chong Han , Dainis Kaldre , Sean M. Kelly , Sebastian Herold , Christian Leitner
IPC: C07D401/04 , B01J23/44 , B01J23/755
CPC classification number: C07D401/04 , B01J23/44 , B01J23/755
Abstract: Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.
-
公开(公告)号:US11780834B2
公开(公告)日:2023-10-10
申请号:US17110607
申请日:2020-12-03
Applicant: Hoffmann-La Roche Inc. , GENENTECH, INC.
Inventor: Cheol Keun Chung , Jie Xu , Hans Iding , Kyle Clagg , Michael Dalziel , Alec Fettes , Francis Gosselin , Ngiap-Kie Lim , Andrew McClory , Haiming Zhang , Paroma Chakravarty , Karthik Nagapudi , Sarah Robinson
IPC: C07D471/04 , C07D403/14
CPC classification number: C07D471/04 , C07D403/14 , C07B2200/13
Abstract: Provided herein are solid forms, salts, and formulations of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol, processes and synthesis thereof, and methods of their use in the treatment of cancer.
-
公开(公告)号:US20220081413A1
公开(公告)日:2022-03-17
申请号:US17398345
申请日:2021-08-10
Applicant: Genentech, Inc. , Hoffmann-La Roche Inc.
Inventor: Ngiap-Kie Lim , Jeff Shen , Lauren E. Sirois , Jacob C. Timmerman , Etienne Trachsel , Nicholas A. White , Jie Xu , Haiming Zhang , Stephan Bachmann , Raphael Bigler , Kyle Bradley Pascual Clagg , Antonio Dipasquale , Francis Gosselin , Ugo Jonathan Orcel , Roland Christoph Meier
IPC: C07D401/14
Abstract: Provided herein are methods of synthesizing quinazoline compounds comprising at least one atropisomeric center.
-
公开(公告)号:US10954234B2
公开(公告)日:2021-03-23
申请号:US16443515
申请日:2019-06-17
Applicant: Genentech, Inc. , Hoffman-La Roche, Inc.
Inventor: Cheol Keun Chung , Jie Xu , Hans Iding , Kyle Clagg , Michael Dalziel , Alec Fettes , Francis Gosselin , Ngiap-Kie Lim , Andrew McClory , Haiming Zhang , Paroma Chakravarty , Karthik Nagapudi , Sarah Robinson
IPC: C07D471/04 , C07D403/14 , A61P35/00 , A61P35/04
Abstract: Provided herein are solid forms, salts, and formulations of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol, processes and synthesis thereof, and methods of their use in the treatment of cancer.
-
公开(公告)号:US20170313704A1
公开(公告)日:2017-11-02
申请号:US15652776
申请日:2017-07-18
Applicant: Genentech, Inc.
Inventor: Ngiap-Kie Lim , Haiming Zhang , Chong Han
IPC: C07D471/14
CPC classification number: C07D471/14 , C07D471/04
Abstract: Processes are described for the preparation of tricyclic lactam compound of Formula (I), having the structure and intermediates useful for the preparation of (I).
-
-
-
-
-
-
-
-
-